Abstract:Introduction: Noninsulin dependent diabetes mellitus (NIDDM) or Diabetes Type 2 is a major health challenge worldwide. In 2014 the World Health Organization (WHO) revealed that the percentage of adults with fasting glucose ≥ 7.0 mmol/L accounts for 9% globally. Moreover, the highest percentage was in the Eastern Mediterranean Region with 26.8 ± 0.4%. Type 2 diabetes is a complex metabolic disorder associated with high level of glucose in blood (hyperglycemia) which lead to long-term pathogenic conditions such as: neuropathy, retinopathy, nephropathy and a consequent decrease in quality of life and increased mortality rate. Starch is the main source of energy for most living organisms; in humans it is digested over several stages that involve different amylolytic enzymes, such as α-Amylase and α-Glucosidase. Alpha Amylase is the major secretory product (about 5–6%) of the pancreas and salivary glands, playing a core role in starch and glycogen digestion. The control of postprandial hyperglycemia is an important strategy in the management of Type 2 diabetes; lifestyle modification and/or the use of medications such as insulin and α-Glucosidase inhibitors are the available treatments to date. Acrabose is a prominently used α-Glucosidase inhibitor for diabetes and obesity control, however it has many side effects and limitations. Numerous in vivo studies (REFS) have shown that many plant extracts inhibit the key enzymes of digestion (α-Amylase and α-Glucosidase) and the use of naturally occurring inhibitors is potentially the most effective and safest approaches for treating diabetes. Aims: Short-term aim: To clone, express and purify human α-Amylase protein using different yeast expression systems. Followed by protein (c0)crystallization and structural analysis. Long-term aim: Screening natural products (plant extracts) based on their traditional use followed by co-crystallisation of selected inhibitors. This will be complemented by inhibitors designed in silico based on the ANCHOR.QUERY approach (REF). Finally, identified compounds will be characterised by biophysical and kinetic studies. Methodology: Human α-Amylase has been cloned into two vectors pHIPZ-4 and pPIC9k, each with its own set of primers, restriction enzymes and dedicated expression host (pHIPZ-4: Hansenula polymorpha and pPIC9k: Pichia pastoris, respectively). After transformation, the grown colonies were tested for the presence of the target gene by colony PCR and digestion with cloning enzymes. Positive colonies were re-inoculated in growth media and recombinant plasmid was recovered. The plasmids were then transformed into competent yeast cells by electroporation. For H. polymorpha, cells were grown in minimal media with glucose (MM/G) for two days followed by induction of expression with 0.5% (v/v) MeOH. Protein was purified by lysing the cells and passing the lysate through Ni-NTA beads. Finally protein was identified with by Western blot using HisProbe-HRP antibody. Results: Human α-Amylase gene was successfully cloned in both vectors pHIPZ-4 and pPIC9k according to colony PCR and digestion judgment on Agarose gel. However, the expression of α-Amylase protein in H. polymorpha system is insufficient to support the downstream work. Analysis of secreted expression using Pichia pastoris is currently underway and the results will be reported at the meeting. Conclusion: Human α-Amylase was successfully cloned in both vectors and stably transformed to E. coli competent cells. The positive colonies were confirmed for the present of targeted gene then transformed to yeast cells.

Sequence-specific ~(1)H-NMR Assignment of Proton Resonances of the Amaranth Alpha-Amylase Inhibitor AAI and Structure Analysis

Solution Structure of the Major α-Amylase Inhibitor of the Crop Plant Amaranth

Structure and Oxidative Folding of AAI, the Major Alfa-Amylase Inhibitor From Amaranth Seeds

<sup>13</sup>C Solid-State NMR Study of Structural Heterogeneity in Peptides Containing Both Polyalanine and Repeated GGA Sequences as a Local Structural Model of<i>Nephila</i><i>c</i><i>lavipes</i>Dragline Silk (Spidroin 1)

Structure of Model Peptides Based on Nephila Clavipes Dragline Silk Spidroin (masp1) Studied by 13C Cross Polarization/Magic Angle Spinning NMR

Sequence and Structure-Guided Engineering of Urethanase from Agrobacterium Tumefaciens D3 for Improved Catalytic Activity

Amino acid sequences of a hyperglycaemic hormone and its related peptides from the Kuruma prawn, Penaeus japonicus

Crystal structure of the polyextremophilic alpha-amylase AmyB from Halothermothrix orenii: details of a productive enzyme-substrate complex and an N domain with a role in binding raw starch

Molecular cloning and characterization of an alpha-amylase inhibitor (TkAAI) gene from Trichosanthes kirilowii Maxim.

Structure-based protein engineering for alpha-amylase inhibitory activity of plant defensin

Unveiling α-Amylase Inhibition: A Bioinformatics Perspective on Peptide Properties and Amino Acid Contributions

Cloning and functional expression of the gene encoding an inhibitor against Aspergillus flavus alpha-amylase, a novel seed lectin from Lablab purpureus (Dolichos lablab)

Heterologous expression of an α-amylase inhibitor from common bean (Phaseolus vulgaris) in Kluyveromyces lactis and Saccharomyces cerevisiae

Investigation of AMA Synthase from Pyrenophora teres f. teres 0‐1 for the Synthesis of Aspergillomarasmine A Analogues and Non‐canonical Amino Acids

Identification of the AMA Synthase from the Aspergillomarasmine A Biosynthesis and Evaluation of Its Biocatalytic Potential

Statistical Characterization of Food-Derived α-Amylase Inhibitory Peptides: Computer Simulation and Partial Least Squares Regression Analysis

Rational Design of Water-Soluble Supramolecular Aiegen with Ultra-High Quantum Yield, and Its Application in Α-Amylase Activity Detection and Wash-Free Lysosome Imaging

Solution Structure of PAFP-S: A New Knottin-Type Antifungal Peptide from the Seeds of Phytolacca Americana,

A Novel Amidase Signature Family Amidase from the Marine Actinomycete Salinispora Arenicola CNS-205

Identification and Structural Analysis of Natural Product Inhibitors of Human Alpha-Amylase to Target Diabetes Mellitus

alpha-Amylase gene of Streptomyces limosus: nucleotide sequence, expression motifs, and amino acid sequence homology to mammalian and invertebrate alpha-amylases